Evidence map›Paper›PMID 32615154›Full record

ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2020

Androgen deprivation and SARS-CoV-2 in men with prostate cancer.

M Koskinen, O Carpen, V Honkanen, M R J Seppänen, P J Miettinen, J A Tuominen, T Raivio

Abstract readLetterComment
In one paragraph

Article in Annals of oncology : official journal of the European Society for Medical Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. [Prostate cancer, androgen deprivation, and risk of COVID-19 infection : A systematic review and meta-analysis].Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie · 2022
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Extraordinary claims without extraordinary evidence: controversy on anti-androgen therapy for COVID-19.Journal of the European Academy of Dermatology and Venereology : JEADV · 2021
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. A Comment on Coronavirus Disease 2019 and the Hair.International journal of trichology
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

M KoskinenHelsinki Biobank, Helsinki University Hospital, Helsinki, Finland; Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
O CarpenHelsinki Biobank, Helsinki University Hospital, Helsinki, Finland; Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
V HonkanenGeneral Administration, Helsinki University Hospital, Helsinki, Finland.
M R J SeppänenNew Children's Hospital, Pediatric Research Center, Helsinki University Hospital, Helsinki, Finland.
P J MiettinenNew Children's Hospital, Pediatric Research Center, Helsinki University Hospital, Helsinki, Finland.
J A TuominenGeneral Administration, Helsinki University Hospital, Helsinki, Finland.
T RaivioNew Children's Hospital, Pediatric Research Center, Helsinki University Hospital, Helsinki, Finland; Stem Cells and Metabolism Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland. Electronic address: taneli.raivio@helsinki.fi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Coronavirus InfectionsPandemicsPneumonia, ViralProstatic NeoplasmsSevere Acute Respiratory SyndromeAndrogen AntagonistsBetacoronavirusCOVID-19HumansMaleSARS-CoV-2Androgen Antagonists

Identifiers

PMID32615154
PMCPMC7323668

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.